Tag: CAPA

Investigation of Air Entrapment Defects Following a Packaging Change Encountering an air entrapment defect post-packaging change is a significant concern that can lead to product failure and regulatory scrutiny. This…

Understanding pH Drift after a Packaging Change: An Investigation Approach In a pharmaceutical manufacturing environment, even minor changes in packaging can yield unexpected quality deviations—such as pH drift. This phenomenon…

Investigation of Texture Non-Uniformity After Bulk Hold in Pharmaceutical Manufacturing Texture non-uniformity in ointments and creams can severely impact product quality, leading to customer complaints and regulatory scrutiny. Understanding the…

Understanding Air Entapment Defects in Ointments During Stability Studies The presence of air entrapment defects during stability studies can lead to significant challenges in pharmaceutical manufacturing and quality assurance. Such…

Addressing Viscosity Drift After Bulk Hold: A Comprehensive Investigation Guide Viscosity drift after a bulk hold can lead to significant quality concerns in pharmaceutical formulations, especially in ointments and creams.…

Investigation of Microbial Contamination During Transfer: Insights into Formulation and Process Microbial contamination during the transfer stage of pharmaceutical manufacturing presents a significant risk, particularly for ointments and creams. This…

Addressing Texture Non-Uniformity in Homogenization: A Risk Management Approach Texture non-uniformity during homogenization poses significant challenges in pharmaceutical manufacturing, particularly for ointments and creams. Such defects can lead to product…

Investigating Tube Leakage During Stability Studies: Ensuring Inspection Readiness In pharmaceutical manufacturing, maintaining product integrity is paramount to regulatory compliance and patient safety. One of the pressing concerns facing quality…

Addressing Phase Separation During Transfer: Ensuring Inspection Readiness Manufacturers of ointments and creams often face the challenge of achieving product stability and integrity during the transfer process. A critical issue…

Analyzing Microbial Contamination Risks During Stability Studies: Formulation and Process Investigations Microbial contamination during stability studies poses significant risks to pharmaceutical products, particularly ointments and creams. This issue can lead…

Investigating Air Entrapment Defects in Stability Studies: A Comprehensive Approach Air entrapment defects during stability studies can pose significant risks to product integrity and regulatory compliance in pharmaceutical manufacturing. This…

Analyzing pH Drift Risks During Stability Studies in Pharmaceutical Manufacturing In the pharmaceutical manufacturing landscape, maintaining the integrity of formulations throughout stability studies is critical to ensuring product efficacy and…